A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

Author: Ma Cynthia   Mandrekar Sumithra   Alberts Steven   Croghan Gary   Jatoi Aminah   Reid Joel   Hanson Lorelei   Bruzek Laura   Tan Angelina   Pitot Henry   Erlichman Charles   Wright John   Adjei Alex  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.2, 2007-02, pp. : 207-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content